OSI Pharmaceuticals (OSIP) - formerly Oncogene Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (82)	2/14/2000 8:08:00 PM
From: Miljenko Zuanic	Read Replies (1) of 447

They done it! They found magic words"! biz.yahoo.com <<Additionally, we have strengthened our discovery technology portfolio by entering into a licensing agreement with American Cyanamid that complements our newly-acquired GPCR technology. This is an important step towards building a strong functional genomics capability* in this area.>> Maybe they will do better if they return old name, OncoGENE.com! Glad to see that KDUS technology in their hand is free from SIBI/MRK patents. <<OSI also signed a licensing agreement with the R.W. Johnson Pharmaceutical Research Institute for OSI's gene transcription patents, further validating this expanding patent estate. >> $25K they call further patents validation? They can make more money on a daily base with gen.com daytradeing! <<In addition, OSI initiated Phase I trials of its anti-cancer agent with Pfizer, ...>> OSI?? What, PFE is so busy counting Lipitor daily scripts that they can focus on R&D staff? Best, Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next